SB3521 amends the Illinois Controlled Substances Act to enhance the confidentiality and use of prescription monitoring data.
SB3521 modifies the Illinois Controlled Substances Act to strengthen the confidentiality of prescription monitoring data. It mandates that the Department of Public Health and the Prescription Monitoring Program coordinate to review patient data for potential opioid use disorder risks. The bill outlines specific conditions under which confidential information can be disclosed, including to law enforcement and governing bodies for investigations.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.